Ke kinua ʻAiwiat: nā ʻōlelo no ka hoʻohana ʻana

Loaʻa ka lāʻau lapaʻau i nā hopena antipyretic, analgesic.

ʻO ka hana o ka hana o Aspinat e pili ana i ka pale ʻana i ka hana o ka cyclooxygenase 1 a me 2 mau enzyme, ma lalo o ka mana o ka prostaglandins e synthesized (ma muli o ia ʻeha hōʻeha a ka māla ʻana ma ka wahi o ka kaʻina hana).

Me ka hoʻohaʻahaʻa ʻana i ka pae o ka prostaglandins ma ka wahi o thermoregulation i loko o ka lolo, hoʻonui nui ʻia ka hōʻaiu a me ka lumen o nā kīnā moku, kahi mea e hoʻolako i hopena antipyretic. ^ E Ha yM. ʻO ka hopena analgesic ma muli o ka hopena koʻikoʻi a me kēlā me kēia hopena o ka lāʻau.

Hoʻopili ka Acetylsalicylic acid i ke kāpili ʻana o ka huina thromboxane A2 i loko o nā kōpona koko, platelets, e hōʻemi ana i ka thrombosis, pīpī platelet a me kā lākou hoʻohui. Kau ʻia hopena antiplatelet lana no ka hebedoma ma hope o hoʻokahi ka wai o ka lāʻau. Ua hoʻomaopopo ʻia ua hoʻomaʻamaʻa ʻia kēia hopena i nā kāne.

Ma ka hoʻomaʻamaʻa ʻana me ka waikawa acetylsalicylic, hoʻemi ka pilikia o ka hoʻomohala ʻana i kahi ʻano ʻole ʻole o ka angina pectoris, hoʻemi ʻia ka myocardial infarction, a me ka make o ka make mai nā maʻi o ka ʻōnaehana cardiovascular.

Hoʻohana pono ʻia ka lāʻau Aspinat no ka pale mua a me ka mālama lua ʻana o ka myocardial infarction, ʻoi aku hoʻi i nā kāne ʻoi aku ka nui o nā makahiki he 40.

Hoʻonui ka palena o 6 mg i kēlā me kēia lā i ka manawa prothrombin a pale i nā synthes prothrombin i ka ʻōnaehana ʻōwili. He mea nui ia e noʻonoʻo inā lawe ana i ka acetylsalicylic acid, ʻo ka hopena o ka hopena o ke koko a me nā ʻano like ʻole nā hoʻopiʻi hemorrhagic i ka wā a ma hope o ka wawaʻi ʻana.

Hoʻopau ka aspinate i ka hoʻoulu ʻana o ka vitamina K-hilinaʻi coagulation factor 2, 7, 9 a 10. E hoʻomāhuahua ai ka lāʻau lapaʻau i ka hana fibrinolytic o ke koko koko, e hoʻoulu ai i ke kaʻina kūʻokoʻa. waawa uric mai ke kino i loko o nā hua liʻiliʻi (ma muli o ke kau hou ʻana i ka ʻōmole o nā ʻōnaehana renal).

Me ka blockade o cyclooxygenase-1 i ka mucosa gastric, hana i ka hana o ke gastroprotective (pale) prostaglandins a emi mai, e hiki ai i ka ulceration o ka pā o gastric a me ka hoʻomohala ʻana i ke koko.

ʻO ka hopena liʻiliʻi e hoʻonāukiuki i ka mucosa gastric e hoʻomoʻa ʻia e nā puka effabilitycent kūikawā nui o ka acetylsalicylic acid, enteric-soluble a me nā puka dosage, kahi mau buffers.

ʻO nā hoʻomākaukau e hoʻomākaukau ana acetylsalicylic acid

E hoʻokuʻu i ke ʻano

Nā Pahu (Aspinat, Aspinat Cardio, Aspinat Plus, Aspinat 300), nā papaha effasescent (Aspinat, Aspinat C).

Aspinat: acetylsalicylic acid (100 mg a i ʻole 500 mg).

Aspinat Cardio: ka acetylsalicylic acid (50 mg a i 100 mg), nā puna: MCC, starch 1500, aerosil (colloidal silicon dioxide), stearic acid, enteric coating: ACRYL-IZ (copolymer o ka waikawa methacrylic me ka acyl acrylate 1: 1, titanium dioxide, talc, triethyl citrate, anhydrous colloidal silicon oxide, sodium bicarbonate, sodium lauryl sulfate), copovidone, hydroxypropyl cellulose (Klucel).

Aspen 300: acetylsalicylic acid (300 mg), enteric coating.

Aspinat Plus: acetylsalicylic acid (500 mg), caffeine (50 mg).

Aspinat S: acetylsalicylic acid (400 mg), acid ascorbic (240 mg).

Aspinat:

• 10 papa i loko o kahi pā o ka bezjacheykovoy contour, 1 a i ʻole 2 mau ʻāpana i kahi pahu kīwā.
• 10 pe 20 pcs. i ka pahu polū i loko o ka pūlima pepa,
• 10 mau papa i loko o kahi pā kihi, 1 a i ʻole 2 mau pā i loko o ka pahu pepa.
• 12 papa hoʻomōhule i ka hihia polimeria ma ka pūlani pepa.

Aspinat Cardio:

• 10 kamepiula i nā pahu blister, 1, 2, 3, 5, 10 packets in a cardboard box,
• 10, 20, 30, 50 a i ole 100 pcs. i kahi pahu polū i loko o ka pūlima pepa.

Aspen 300:

• 10 kamepiula i pack contour bezjacheyakovoy, 1, 2, 3, 5 a 10 mau pūʻulu paha i kahi pahu pahu
• 10, 20, 30, 50 a i ole 100 pcs. i ka pahu polū i loko o ka pūlima pepa,
• 10 kamepiula i nā pahu pōpō, 1, 2 a i ʻole 10 mau pā i kahi pahu kāʻai.

Aspinat Plus:

• 10 kamepiula i nā pahu pōpō, 1, 2, 3 a 5 paha mau kāleka i kahi pahu kāleka,
• 10, 12, 15, 16, 20 a 30 mau pcs. i kahi pahu polū i loko o ka pūlima pepa.

Aspinat S: 10 pcs i kahi hihia polū i loko o kahi ʻāpana pepa.

Ka hana lāʻau lapaʻau

ʻO ka maikaʻi o ka puka hopena i ka lāʻau e hoʻohālikelike ai i ka waikawa acetylsalicylic kūloko i nā papa he mea ʻoi loa a me ka wikiwiki o ka hana ʻana o ka mea hana a me kona hoʻomanawanui maikaʻi.

• ʻO ka hōʻeha ʻeha a me nā hōʻoluʻolu i nā pākeke o nā ʻano kumu mua: ka ʻeha (me nā mea e pili ana i ka hoʻihoʻi ʻana i ka ʻatikala waipuna), ka ʻūhā ʻana, ka migraine, neuralgia, radicular radicular syndrome, ka ʻeha a me ka ʻeha pūluhi, ʻeha i ka wā menstruation.
• Hoʻonui ka nui o ke kino i ke anu a me nā maʻi ʻē aʻe a me nā maʻi hou (ma nā pākeke a me nā keiki ma mua o 15 mau makahiki i ka nui o nā makahiki).

Aspinat Cardio:

• Ka pale ʻana o ka maʻi myocardial acute i mua o nā mea i ke koʻikoʻi (e.g. diabetes mellitus, hyperlipidemia, hypertension, obesity, ulaula, ʻelemakule) a me ka myocardial infarction,
• ka lani panghina,
• pale ʻana i ka huakaʻi (me i nā mea maʻi me ka maʻi cerebrovascular transient)
• ka pale ʻana o ka maʻi cerebrovascular transient,
• ka pale ʻana o ka thromboembolism ma hope o ka hoʻokolohua a me ka wawao ʻana i ka maʻi vascular (e.g. coronary artery bypass grafting, carotid artery endarterectomy, arteriovenous shunting, carotid artery angioplasty).
• ka pale ʻana o ka thrombosis vein hohonu a me ka thromboembolism o ka pulmonary artery me nā lālā ona (no ka laʻana, me ka lōʻihi o ka immobilization ma muli o ka hoʻopili nui o ka wehe ʻana).

Nā Hoʻohui

• ʻO ka hypersensitivity i ASA, nā mea lawe o ka lāʻau lapaʻau a me nā NSAID,
• eroses a me ulcerative lesi o ka gastrointestinal tract, gastrointestinal koko,
• hemorrhagic diathesis,
• Hoʻokomo ʻia ka palaka bronchial ma ka lawe ʻana i ka salicylates a me nā NSAID, ka Triad Widal triad (kahi hui pū ʻana o ka poma bronchial, e hoʻi hou ana i ka polyposis nasal, paranes sinuses a me ka intolerance iā ASA).
• hoʻohui me ka methotrexate ma ke ʻano o 15 mg i hoʻokahi pule a ʻoi paha.
• renal hepatic failed,
• hapai (I and III trimester),
• lactation
• makahiki i 18 makahiki.

Me ka mālama:

• kohola
• pālahalaha maʻi
• ka mōʻaukala gastrointestinal ulcerative lesions a gastrointestinal pehu, pale a me ka ole hana, bronchial asthma, maʻi pēpē maʻi, hay fever, nasal polyposis, maʻi kūloko o nā mea ola ʻē aʻe,
• II trimester o wahine hāpai,
• hui me methotrexate ma loko o kahi haʻahaʻa o lalo i ka 15 mg i hoʻokahi pule,
• ka hemahema o ka huaora K a me ka glucose-6-phosphate dehydrogenase.

ʻLoe a me ke kākele

I loko, e inu nei i nā waiila he nui. Pono e hoʻoheheʻe ʻia nā papa palepona i 100-200 mg o ka wai kuke i ka lumi lumi.

Hoʻoholo ʻia ka nui o ka maʻi a me ka papa o ka komo ʻana e ka kauka hele mai, no ka mea maʻa aku nei nā mea a pau e pili ana i ka makahiki a me ke ʻano o ka mea maʻi.

Me ka ʻeha nui, hiki iā ʻoe ke lawe i ka 400-800 mg o ka acetylsalicylic acid 2-3 mau lā i kahi lā (akā ʻaʻole kaʻoi aku ma ka 6 g i kēlā me kēia lā). E like me ka mea lawelawe antiplatelet, hoʻohana liʻiliʻi nā doses liʻiliʻi - 50, 100, 300 mg o ka mea ikaika. No ka huiki, ua ʻōlelo ʻia e lawe i ka nui o ka 0.5-1 g o ka acetylsalicylic acid i kēlā me kēia lā (inā pono, hiki ke hoʻonui ʻia ka paʻakai ma ka 3 g). ʻAʻole pono nā lōʻihi o ka mālamaʻana ma mua o 14 mau lā.

Aspinat Cardio:

Ke hana ʻia nei ka lāʻau lapaʻau no ka hoʻohana lōʻihi. Hoʻoholo ʻia ka lōʻihi o ka hopena e ke kauka hele mai.

• ʻO ka pale ʻana i nā hihia o nā mea hoʻowalewale ʻoi ʻia ka myocardial infarction he 100-200 mg / lā (pono e ʻoka ʻia ka papa mua no ka wikiwiki o ka komo ʻana).
• ʻO ka paleʻana i ka infarction myocardial mua i mua o ka hopena o nā mea pilikia - 100 mg / lā.
• Kāohi i ka hoʻihoʻi pinepine o myocardial infarction, ka paʻa ʻole, kaʻi ʻana i ka hōʻeha ʻana a me ka ulia cerebrovascular transient, pale ʻana i ka hoʻopiʻi thromboembolic ma hope o ke kauā ʻana a i ʻole nā ​​haʻawina invasive - 100 mg / lā.
• ʻO ka paleʻana i ka thrombosis vein hohonu a me ka thromboembolism o ka pulmonary artery me kāna mau lālā he 100-200 mg / lā.

Loaʻa ka hopena

• Nā kūmole pale: urticaria, Edema a Quincke.
• Mai ka pānaʻi ʻana: nā hopena anaphylactic.
• Mai ka ʻeha o ka gastrointestinal: nausea, ka ʻōpio, ka luaʻi ʻana, ka ʻeha ma ka ʻōpū, ka ʻōpū o ka membrane o ka ʻōpū a me ka duodenum, ʻo ia hoʻi perforated, gastrointestinal koko, hoʻonui i ka hana o nā ate enzyme.
• Mai ka papa hana hanu: bronchospasm.
• Mai ka pūnaehana hemopoietic: hoʻonui nui i ke koko, anemia (loaʻa pinepine).
• Mai ka ʻaoʻao o ka pūnaehana loko ma waena: nā dizziness, tinnitus.

Ke keu

E makaʻala ʻoe e pili i ka hoʻohālikelike i ka ʻelemakule a ma nā keiki liʻiliʻi (therapeutic overdose a i ʻole ka hōʻino ʻona ʻole, ʻike ʻia i nā keiki ʻuʻuku liʻiliʻi), ka mea e alakaʻi ai i ka make.

ʻO nā hōʻailona o kahi overdose o ka hōʻeha maʻalahi: ka nausea, luaʻi, tinnitus, lohe kaumaha, dizziness, confing.

Hoʻomaʻamaʻa: hōʻemi ʻemi.

Nā Hōʻeha Aʻe Kāpae: ka wela, kaomi, ka maʻi ketoacidosis, ka ea respalic alkalosis, coma, cardiovascular a me ka hanu maikaʻi ʻole, hypoglycemia koʻikoʻi.

Hoʻomaʻamaʻa: Ke hoʻokipa koke nei i kahi keʻena loea no ka hōʻeha o ka maʻi maʻamau - ka gastric lavage, ka hoʻoholo ʻana o ka hoʻāla lula-acid, ka alkaline a me ka diuresis alkaline i hoʻopaʻa ʻia, ka hemodialysis, ka hoʻolauna o nā mea hoʻonā, ka hoʻohālikelike ana i ka carbon activated, the therapyatic therapy.

Ke lawe nei ʻoe i ka diuresis alkaline, pono e hoʻokō i nā waiwai pH ma waena o 7.5 a 8. E hana ʻia nā waikawa alkaline paʻa i ka wā e ʻoi aku ka nui o nā salicylates i ka plasma ma mua o 500 mg / l (3.6 mmol / l) i nā pākeke a 300 mg / l (2. 2 mmol / l) - i nā keiki.

Hoʻohui nūhou

Me ka hoʻohana like ʻana o ASA e hoʻonui i ka hana a nā lāʻau lapaʻau e hiki mai ana:

• methotrexate - ma muli o ka emi ʻana o ka hoʻomaʻemaʻe renal a me kona neʻe ʻana mai ka kamaʻilio ʻana me nā protein,
• heparin a me nā indicoagulants kūloko - ma muli o ka hana platelet i kau ʻole ʻia a me ka neʻe ʻana o nā anticoagulants kūlike mai ka kamaʻilio ʻana me nā protein,
• Nā lāʻau lapaʻau thrombolytic a me antiplatelet (ticlopidine),
• digoxin - ma muli o ka emi ʻana o kāna hana renal,
• ʻO nā aihue hypoglycemic (a me nā derivatives o ka sulfonylurea) - ma muli o nā waiwai hypoglycemic o ASA pono i nā kiʻekiʻe nui a me ka neʻe ʻana o ka derogatives o sulfonylurea mai ka kamaʻilio ʻana me nā protein.
• valproic acid - ma muli o kona kaʻe ʻana mai ka kamaʻilio ʻana me nā protein.

Hoʻomaopopo kahi hopena hoʻohui i ka wā e lawe ana i ka ASA me ka waiʻona.

Hoʻolaha ʻo ASA i ka hopena o nā lāʻau uricosuric (benzbromarone) ma muli o ka hoʻokūkū tubular hoʻopau ʻana i ka waikū uric.

I ka hoʻonuiʻana i ka hoʻopauʻana o salicylates, hoʻonāwaliwali nā ʻōnaehana corticosteroids i ko lākou hopena.

ʻŌpū a me ka lactation

ʻO ka hana nui ʻana o nā salicylates nui i loko o ka makahi mua o ka hāpai ʻia e pili pū me ka nui o ka piʻi ʻana o nā pūhaka hoʻomaʻamaʻa a ʻo nā keiki (split palate, defects heart).

I ka lua o ka wā hapalua o ka hapai ʻana, hiki ke kuhikuhi ʻia nā salicylates me ka nānā wale ʻia o ka hōʻemi a me ka pono.

I ka trimester hope loa o ka hāpai ʻana, ka salicylates ma kahi kiʻekiʻe nui (ʻoi aku ma mua o 300 mg / lā) e hoʻokaʻawale i ka hana, hana mua i ka ductus arteriosus i ka pūpū, hoʻonui nui ʻia ka huhū ma ka makuahine a me ka maʻi fetus, a me ka hoʻokele ma mua o ka hānau ʻana e hōʻeha i ka hemorrhage intracranial, aemaise i nā pēpē ma mua.

ʻO ke koho ʻana o salicylates i ka lā hope loa o ka hapai i contraindicated.

ʻO Salicylates a me kā lākou metabolites i loko o nā liʻiliʻi liʻiliʻi e komo i loko o ka waiū umauma. Hōʻalo ka hoʻolilo ʻana o ka salicylates i ka wā lactation me ka hoʻomohala ʻia ʻana o nā hopena maikaʻiʻole i ke keiki ʻaʻole pono me ka hoʻomaʻamaʻa ʻana o ka ʻōpiopio. Eia nō naʻe, me ka hoʻohana mau ʻana o ka lāʻau lapaʻau a i ʻole ke koho ʻana i kahi papa kiʻekiʻe, pono ke hoʻopau koke ka mālama ʻana i ka umauma.

Nā ʻōlelo kikoʻī

Hoʻohana wale ʻia ʻo Aspen ma hope o ke koho ʻana i kahi kauka.

Hiki i ka lāʻau lapaʻau ke hāʻawi i ke koko, a me ka hoʻonui ʻana i ka lōʻihi o ke kāne. Hoʻonui ka Acetylsalicylic i ka hopena o ke koko i ka hihia.

ʻAʻole hoʻohana ʻo Aspinate i ka wā kamaliʻi ma muli o ka hopena o ka maʻi Reye.

Hoʻokomo ʻia nā hopena i ka hiki ke lawe i kahi kaʻa / me nā ʻenehana.

Nā hōʻailona no ka hoʻohana ʻana

Kauoha ʻia ʻo Aspen no ka hoʻokuʻu ʻana ʻiliʻala maʻi, e pili pū ana i nā maʻi maʻi he nui a me ka maʻi.

I kēia manawa, ʻaʻohe hana o ka acetylsalicylic e mālama ai pericarditisrula hulu rōlani wahine, rheumatism a me nā huakaʻi hopohopo myocarditis.

ʻAno nā ʻōlelo aʻoaʻo no ka hoʻohana ʻana ʻo Aspinat e kuhikuhi i ka lāʻau lapaʻau e hoʻokō i ka hopena antiplatelet (ma ke ʻano he 300 mg i kēlā me kēia lā) no nā mea maʻi me ka angina ka paʻa ʻana, ka maʻi puʻukui coronary, hōʻano hou i ka myocardial infarction, ischemic stroke, me ka prostense heart valves, me ka stent paʻa, ma hope. ka coronary angioplasty.

Hoʻohana ʻia ka lāʻau lapaʻau e hōʻoluʻolu i nā ʻeha o nā ʻano kumu. lumbago, arthralgia, ʻeha, me ka hōʻeha o ka migraine hōʻeha ʻia e ka hoʻoiho ʻana i nā hōʻailona), neuralgia, hōʻeha ka niho, algomenorrhea, ʻeha radicular syndrome, ʻehaʻeha o ka naʻau.

Ma ka maʻi āpau a me nā maʻi maʻi maʻi, ua hōʻike ʻia ʻo Aspinat e hoʻonui i nā inikua e hoʻomanawanui i ka hoʻomanawanui (ke kūpaʻa) i nā lāʻau anti-inflammatory non-steroidal i nā poʻe maʻi e hōʻeha nei "Aspirin triad" a "ʻAmelika Hanii".

Nā hopena hopena

Hiki ke hopena i ka hōʻeha, ke maʻi maʻi, Hōʻike Reye maʻi (ka hiki wikiwiki o ka hana o ka ate, ka hōʻoki ʻana i ka momona momona o ke akea a me ka encephalopathy), nā hana hoʻonaninani, nā pane kūlohelohe i ke ʻano o ka bronchospasm, rashes ka peʻe a me ka angioedema.

Hiki i ka acetylsalicylic acid ke kumu i ka "aspirin triad" a me "aspirin asthma" ma muli o ke kūkulu ʻana i ka mīkini hapten.

Hoʻololi ʻia ka lōʻihi o ka mālama ʻana me ka ʻeha, ka ʻike maka, nā ʻōpū a me nā ulia o ka uluna o ka hoʻowalewale ʻana, ka tinnitus, ka luaʻi ʻana, ka huki, ʻālaʻi nephroticpaprosary necrosis, bronchospasm, ʻike mua i ka ʻike auditory, hypocoagulation, ke nephritis interstitial, hypercalcemia, azotemia prerenal, ʻūhā, i nui ka nui o nā enzyme o ka ate, hoʻonui ʻia i nā hopena o ka puʻuwai puʻuwai, meningitis aseptic.

ʻO ka hoʻonaninani, nā ʻōlelo no ka hoʻohana ʻana (Ke ʻano a me ke ʻano)

Hoʻololi ʻia nā papa o Aspinat soluble e hoʻoheheʻe ʻia i ka liʻiliʻi liʻiliʻi ma mua o ka hoʻohana: 2-3-8 mau manawa i ka lā ma 400-800 mg (akā ʻaʻole iʻoi aku ma mua o 6 mau grama).

Hoʻohana ka Acetylsalicylic acid i loko o nā waihona o 50-70-100-300-325 mg e hoʻohana e hoʻokō hopena antiplatelet, ma kahi lemona ʻoi aku i ka 325 mg - e hoʻokō analgesic a me ka hopena anti-inflammatory.

I ka hoʻopili nui koho 100 mg no ka 1 kg i ka lā no 5-6 mauʻu.

Me nā ʻeha koʻikoʻi a me nā ʻeha lohi Ua kuhikuhi ʻia nā pākeke he 0.5-1 mau minuke i kēlā me kēia lā (no 3 mauʻu).

Pono e lōʻihi aku ka lōʻihi o ka terapi ʻo Aspinat i nā lā 14.

Pono e hoʻohemo ʻia nā ʻano hua o ka lāʻau i ka 100-200 ml o ka wai ma mua o ka hoʻomaʻamaʻa ʻana, ʻoi aku ma hope o ka pāʻina.

Hiki i ka lōʻihi o ke kauʻana ke loli mai ka hoʻokahi wai i kekahi mau mahina.

No nā mea maʻi i loaʻa i ka infarction myocardial, ua kuhikuhi ʻia ka lāʻau lapaʻau no ka pale ʻana i ka lua ma kahi o 40-325 mg pākahi i kēlā me kēia lā (ʻo ka nui loa ka laʻana he 160 mg).

Hoʻopili i ka maikaʻi o ka rheological o ke koko ma o ka hoʻohana ʻana i 0.15-0.25 ka nui o ka acetylsalicylic acid i kēlā me kēia lā (hana i ke ʻano no kekahi mau mahina).

I kahi papa o 300-325 mg i kēlā me kēia lā, ke kāohi nei ka lāʻau i ka hōʻuluʻulu ʻana o ke koko cellelet.

Ithromboembolism ka puka ʻana o ka cerebral, me nā hōʻeha kūhoole cerebrovascular i nā kāne, ʻo 325 mg i kēlā me kēia lā i kuhikuhi ʻia (ʻo ka nui o ka lāʻau lapaʻau ka nui e hoʻonui ana i 1 ka grama i kēlā lā)

Hoʻomaʻamaʻa ka pale pio i ka lawe ʻana ma ka 125-300 mg i ka lā.

No ka pale ʻana i ka wehe ʻana o ka short aortic a me kāna thrombosis, ke kuhikuhi ʻia nei e mālama ʻia ka lāʻau lapaʻau ma o ka wai palaki kūikawā i hoʻokomo ʻia i loko o kahi pā o 325 mg i kēlā me kēia 7 mau hola. Eia kekahi, ʻo ke kaʻi ʻana o ka waha acetylsalicylic waʻakolu ʻekolu lā i ka lā ma kahi manawa o 325 mg i ʻōlelo ʻia (ʻoi loa ka manawa, dipyridamole ua ʻōlelo ʻia no ka hebedoma).

Hoʻohui

Hoʻopili ʻo Aspinate i ka hoʻopā o ka heparin, sulfonamides, nā mānoʻi hypoglycemic, narcotic analgesics, lahui, Co-trimoxazole, kūlohelohe anticoagulants, methotrexate, nā mea i hoʻāpono ʻia nā platelet, thrombolytics.

Hiki i ka lāʻau lapaʻau ke hōʻemi i ka hopena o nā lāʻau diuretic (huluhula, ʻO Veroshpiron), nā lāʻau lapaʻau antihypertensive.

Hōʻihi ka hoʻonui ʻana o ke koko gastrointestinal i ka wā e lawe ana i ka lāʻau lapaʻau e loaʻa ana ka etanol, glucocorticosteroids.

Hoʻonui ʻo Hematotoxicity o Aspen me ka mālama ʻana me nā lāʻau Myelotoxic.

ʻO nā lāʻau lapaʻau Antacid hoʻonui i ka hoʻopili ʻana o ka acetylsalicylic acid.

Pehea e hoʻohana ai: dosis a me ke ʻano o ka mālama ʻana

Nā papa pāheʻe: i loko, i hoʻohemo ʻia i mua o kahi wai liʻiliʻi, 400-800 mg 2-3 mau manawa i ka lā (ʻaʻole iʻoi aku ma mua o 6 g). Ma ka hopena o ka rheumatism nui - 100 mg / kg / lā i ka nui o 5-6.

Hoʻololi ʻia nā papa e pili ana i ka ASA i nā inapo ma luna o 325 mg (400-500 mg) i hoʻohana no ka hoʻohana ʻana i kahi lāʻau lapaʻau analgesic a anti-inflammatory, i nā dosis o 50-75-100-300-325 mg i nā pākeke, ʻo ia ka mea ma ka lāʻau antiplatelet.

I loko, me ka ʻeha a me ka maʻi ʻeha, nā pākeke - 0.5-1 g / lā (a hiki i 3 g), i māhele ʻia i 3 mau puhaka. ʻAʻole pono nā lōʻihi o ka mālamaʻana i nā hebedoma 2.

Hoʻopau ʻia nā papa palepona i 100-200 ml o ka wai a lawe mau ʻia ma hope, ma hope o ka ʻai, hoʻokahi kū hoʻokahi - 0.25-1 g, i lawe ʻia he 3-4 mau lā i ka lā. Ka lōʻihi o ka mālama ʻana - mai kahi hoʻokahi i ka papa hoʻokahi papa.

E hoʻomaikaʻi i nā waiwai o ka rheological o ke koko - 0.15-0.25 g / lā no kekahi mau mahina.

Me ka infarction myocardial, me ka pale ʻana i ka lua ma nā mea maʻi ma hope o ka myocardial infarction, 40-325 mg hoʻokahi i ka lā (e like me 160 mg). E like me ka mea e hoʻopili ai i ka hoʻohui platelet - 300-325 mg / lā no ka manawa lōʻihi. Me nā maʻi cerebrovascular ikaika i ka kāne, ka thromboembolism cerebral - 325 mg / lā me ka hoʻonui ikaika i ka nui o 1 g / lā, no ka pale ʻana i ka hoʻi hou ʻana - 125-300 mg / lā. No ka pale ʻana i ka thrombosis a i ʻole komo ʻana o ka short aortic, 325 mg kēlā me kēia hola 7 i kahi intranasal gastric tube, a laila 325 mg mau waha he 3 mau lā i ka lā (maʻamau i hui pū ʻia me dipyridamole, kahi i hoʻopau ʻia ma hope o hoʻokahi pule, e hoʻomau i ka mālama mau ʻia me ASA).

Me ka rheumatism ikaika i kuhikuhi ʻia (ʻaʻole i kuhikuhi ʻia i kēia manawa) i loko o kēlā me kēia lā o 5-8 g no nā pākeke a me 100-125 mg / kg no nā ʻōpio (15-18 mau makahiki), ʻo ka nui o ka hoʻohana ʻana he 4-5 mau lā i ka lā. Ma hope o 1-2 mau pule o ka mālama ʻana, hoʻemi ʻia nā keiki i ka dosis i 60-70 mg / kg / lā, hoʻomau ʻia ka mālama ʻana o nā pākeke i nā maʻi like, a hiki i ka 6 wiki ka lōʻihi o ka mālama ʻana. Hoʻololi ʻia ka hoʻopau ʻana ma o nā hebedoma 1-2.